Insights

Strategic partnerships Myriad Genetics collaborates with notable biotech leaders like AstraZeneca and SOPHiA GENETICS on genomics-based initiatives such as PrGIS, signaling strong affinity for co-development and validation projects that open doors for joint testing, data sharing, and expanded biomarker validation ventures.

Clinical expansion Recent activity highlights a focus on precision oncology and biomarker-driven treatment decisions, suggesting opportunities to upsell advanced molecular tests and integrated diagnostic solutions to oncology centers and academic medical networks seeking comprehensive genomic profiling.

AI enablement The company has invested in AI-enabled revenue-cycle tools and has a history of refining AI prompts to improve output accuracy, indicating potential for selling AI-assisted workflow optimization, automated reporting, and enhanced data interoperability services.

Cost efficiency Guidance reductions and reimbursement pressure imply a need for value-based offerings, such as bundled testing packages, payer-optimized reimbursement support, and cost-to-care analytics to help customers demonstrate ROI and sustain test adoption.

Digital processing Past collaboration on Image Genius with PwC demonstrates a track record in intelligent document processing and data extraction from pathology reports, presenting opportunities to offer complementary data-automation tools, integration services, and enhanced data capture for client labs.

Similar companies to Myriad Genetics

Myriad Genetics Tech Stack

Myriad Genetics uses 8 technology products and services including Osano, SAP, Figma, and more. Explore Myriad Genetics's tech stack below.

Media & News

Myriad Genetics's Email Address Formats

Myriad Genetics uses at least 4 email formats:
Myriad Genetics Email FormatsExamplePercentage
FLast@myriad.comJDoe@myriad.com
65%
First.Last@myriad.comJohn.Doe@myriad.com
31%
FiLast@myriad.comJoDoe@myriad.com
3%
LastFir@myriad.comDoeJoh@myriad.com
1%

Frequently Asked Questions

What is Myriad Genetics's phone number?

Minus sign iconPlus sign icon
You can contact Myriad Genetics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Myriad Genetics's stock symbol?

Minus sign iconPlus sign icon
Myriad Genetics is a publicly traded company; the company's stock symbol is MYGN.

What is Myriad Genetics's official website and social media links?

Minus sign iconPlus sign icon
Myriad Genetics's official website is myriad.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Myriad Genetics generate?

Minus sign iconPlus sign icon
As of October 2026, Myriad Genetics's annual revenue is estimated to be $500M - $1B.

What is Myriad Genetics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Myriad Genetics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Myriad Genetics have currently?

Minus sign iconPlus sign icon
As of October 2026, Myriad Genetics has approximately 2.9K employees across 6 continents, including North America, Asia and Europe. Key team members include Ceo And Chairman Of The Board: J. A., Vice President Of Product Engineering: H. W. and President: B. B. Explore Myriad Genetics's employee directory with LeadIQ.

What industry does Myriad Genetics belong to?

Minus sign iconPlus sign icon
Myriad Genetics operates in the Biotechnology Research industry.

What technology does Myriad Genetics use?

Minus sign iconPlus sign icon
Myriad Genetics's tech stack includes Osano, SAP, Figma, Microsoft Intune, SailPoint, HubSpot, Wistia and Piwik PRO Core.

What is Myriad Genetics's email format?

Minus sign iconPlus sign icon
Myriad Genetics's email format typically follows the pattern of FLast@myriad.com. Find more Myriad Genetics email formats with LeadIQ.

How much funding has Myriad Genetics raised to date?

Minus sign iconPlus sign icon
As of October 2026, Myriad Genetics has raised $215M in funding. The last funding round occurred on Jul 31, 2025 for $125M.

When was Myriad Genetics founded?

Minus sign iconPlus sign icon
Myriad Genetics was founded in 1991.
Myriad Genetics logo

Myriad Genetics

Biotechnology ResearchUtah, United States1001-5000 Employees

Myriad Genetics operates in the biotechnology research sector, focusing on molecular diagnostic testing and precision medicine. The company is based in Salt Lake City, Utah. It develops molecular tests that help gauge an individual's risk of developing disease or disease progression and inform treatment decisions across medical specialties. 

By providing molecular insights, its tests support clinical decision-making and patient care. In May 2026, Myriad announced the launch of the Prolaris + AI Test.

Section iconCompany Overview

Phone number
Website
myriad.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
MYGN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1991
Employees
1001-5000

Section iconFunding & Financials

  • $215M

    Myriad Genetics has raised a total of $215M of funding over 2 rounds. Their latest funding round was raised on Jul 31, 2025 in the amount of $125M as a Post IPO Debt.

  • $500M - $1B

    Myriad Genetics's revenue is estimated to be in the range of $500M - $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.